Status | Study |
Completed |
Study Name: Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA) Condition: Renal Insufficiency Date: 2008-10-15 |
Completed |
Study Name: Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist Condition: Fibrosis Kidney Failure Renal Insufficiency Date: 2008-08-20 Interventions: Drug: Gadopentetate dimeglumine (Magnevist, BAY86-4882) Patients will be followed for 2 years after the |
Completed |
Study Name: Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis Condition: Nephrogenic Systemic Fibrosis Date: 2008-05-08 Interventions: Drug: Imatinib mesylate 400 mg p.o. daily for 4 months. Dosage was reduced to 200 mg if participants dev |
Completed |
Study Name: Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease Condition: Renal Insufficiency Date: 2008-01-15 |
Completed |
Study Name: Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease Condition: Renal Insufficiency Date: 2008-01-14 |